Launch offer — Full free access. Create your account →
All briefs
SPR-2026-5301·April 12, 2026Published

Illuminating a chemical reaction as one measures the watering of a garden

AI-generated hypothesis · Pre-publication · To be tested experimentally

Photochemistry
Chemical Engineering
Share

Table of contents — full brief

  • Hypothesis and mechanism
    Causal chain, key assumptions, residual unknowns
  • State of the art
    Verified references and counter-evidence (DOIs)
  • Falsifiable predictions
    Quantitative bounds, statistical tests, H0
  • Experimental protocol
    Three phases — in silico → minimal → full
  • Impact analysis
    Novelty, residual gaps, available data
  • Panel review
    Five personas + meta-review

Verified references

4 of 4 references

Detailed panel scores

Methodologist8.2
Accept

The stepwise approach (in silico, minimal validation, full validation) is judged excellent for managing risk and resources. The preliminary modelling phase represents a major methodological strength, permitting refinement of the hypothesis and experimental design prior to any substantial investment.

Domain expert8.0
Accept

The hypothesis is judged to be theoretically sound and well-grounded in core CRE principles. It correctly identifies the LVRPA as the fundamental engineering variable in photochemical reactors, analogous to concentration in thermal reactors, and proposes its active spatial and temporal engineering. This is regarded as a sophisticated and correct application of the PFR/CSTR design philosophy to photochemistry.

Devil's advocate4.5
Weak reject

The hypothesis is built on a sound chemical engineering principle: spatially matching a driving force (photon flux) to a kinetic profile (reactant concentration) to improve performance. This is analogous to optimising temperature profiles in tubular reactors.

Industry reviewer6.5
Weak accept

The panel notes that the finding addresses a critical need for efficiency in a rapidly growing market: photochemical synthesis for the pharmaceutical industry (active pharmaceutical ingredients under expired patents, stereoselective syntheses) and advanced materials (functional polymers). The paying actors would be the chemical development departments of large pharmaceutical companies (Pfizer, Merck, Sanofi) and fine chemistry specialists (BASF, Evonik, CABB).

Funding strategist7.5
Accept

A clear and testable fundamental hypothesis with precise quantitative success criteria (15–40% increase).

Loading your session…
Newsletter

Receive the next SPORE hypotheses

Once or twice a month, in your inbox. No spam, one-click unsubscribe.

Your data stays private. No third-party sharing. GDPR-compliant.

Custom collision

Inspired by this collision?

Request your own on a domain of your choice — free during launch. SPORE crosses your domains, generates a hypothesis, and delivers a complete brief in minutes.

Request my collision →